GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity

Table 5

Analysis of different prognostic factors in 94 PCa patients.

Prognostic parameter	Univariate analysis			Multivariate analysis
	HR	95% CI	value	HR	95% CI	value
Expression of GPM6B (/)	0.180	0.083-0.392	0.001	0.207	0.094-0.456	0.001
Age (≥70 vs. <70)	1.278	0.685-2.384	0.440			n.s.
Clinical stage (III-IV vs. I-II)	4.979	1.941-12.773	0.001			n.s.
Gleason score (≥7 vs. <7)	3.535	1.621-7.706	0.001	2.992	1.344-6.663	0.007
T classification (T3, T4 vs. T1, T2)	3.384	1.801-6.358	0.001	2.278	1.175-4.413	0.015
Lymph node metastasis (present vs. absent)	2.931	1.455-5.903	0.003			n.s.
Distant metastasis (present vs. absent)	3.340	1.781-6.263	0.001			n.s.

n.s.: nonsignificant.